Patents by Inventor Yeon Jee Kahm

Yeon Jee Kahm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION COMPRISING EMP3 INHIBITOR FOR INHIBITING GROWTH OF CANCER STEMCELL AND USE THEREOF
    Publication number: 20240102019
    Abstract: The present invention relates to a composition for inhibiting the growth of cancer stem cells and a use thereof. When treated with the EMP3 inhibitor, cancer stem cells expressing ALDH1 decrease in self-renewal potential, invasiveness, and migration ability and thus are restrained from growing, whereby cancer having stemness properties, which are resistant to conventional anticancer therapies, can be effectively treated.
    Type: Application
    Filed: October 14, 2020
    Publication date: March 28, 2024
    Inventors: In Gyu KIM, Rae Kwon KIM, Yeon Jee KAHM
  • ANTI-TM4SF4 ANTIBODY AND USES THEREOF
    Publication number: 20230002485
    Abstract: The present invention relates to novel antibodies or antigen-binding fragments thereof that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies or antigen-binding fragments thereof exhibit proliferation inhibitory activity of cancer cells so as to effectively prevent or treat cancer, and reduce the self-renewal ability of cancer stem cells to be usefully used even in the treatments of cancer with a poor prognosis in conventional anticancer treatments.
    Type: Application
    Filed: December 4, 2020
    Publication date: January 5, 2023
    Inventors: In Gyu KIM, Rae Kwon KIM, Jai Ha LEE, Chang Kyu HEO, Yeon Jee KAHM, Byung Chul SHIN, Eun Wie CHO, Chun Jeih RYU, Min Kyu KIM, Mun Ju CHOI
  • COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF
    Publication number: 20220403395
    Abstract: The present invention relates to a composition for inhibiting the growth of cancer stem cells, and a use thereof. A WDR34 inhibitor of the present invention inhibits the conversion of cancer cells into cancer stem cells and exhibits activity of inhibiting self-renewal, invasion, and migration of cancer stem cells, and thus can be effectively used as a cancer cell growth or metastasis inhibitor or a cancer stem cell growth inhibitor.
    Type: Application
    Filed: June 28, 2022
    Publication date: December 22, 2022
    Inventors: Rae Kwon KIM, In Gyu Kim, Yeon Jee Kahm